Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer.

Daniel Sanghoon ShinSaroj BasakMysore S VeenaBegoña Comin-AnduixArjun BhattacharyaTien S DongAlbert KoPhilip HanJonathan JacobsNeda A MoatamedLuis AvilaMatteo PellegriniMarilene WangEri S Srivatsan

Published in: Cancer medicine (2024)

The results indicate that APG-157 and immune checkpoint inhibitor combination treatment could potentially lead to improved tumor control.

Keyphrases

combination therapy